Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation
Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.
Archives for September 1, 2015
Boehringer-Ingelheim licenses microbial expression tech for in-house and out
Boehringer Ingelheim has licensed a microbial expression technology from Vectron Biosolutions for use with its own molecules and for customers through its CMO business.
EC wants pharma feedback on clinical trial inspector expectations
Clinical trial inspectors will need a University degree and familiarity with modern data management principles under European Commission proposals.
NIPER says API nano crystal formulation tech will cut drug costs
The National Institute of Pharmaceutical Education and Research (NIPER) in India has created and licensed technology for producing nano-crystal based medicines that it says will cut drug costs.
Pfizer confirms it is evaluating Korea operations amid job cut rumours
Pfizer has confirmed it is in discussion with labour unions in Korea as part of an evaluation of its business in the country.
The hunt for work after red October: Novo cites military experience as a big plus
Novo Nordisk says nuclear submarine veterans’ “mission critical” mentality is suited to pharmaceutical manufacturing environment.